Cite
HARVARD Citation
Naicker, S. et al. (2021). Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. Oncoimmunology. p. . [Online].